Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, WOM, MAT

CirrusMD Launches Abortion Referral Services


DENVER, Jan. 10, 2023 /PRNewswire/ -- CirrusMD, a leading provider of on-demand virtual care, today announced it will provide abortion referral services for pregnant people who need trusted, quality abortion care. This is the most recent initiative supporting the CirrusMD mission of expanding access to high quality care for all people, especially those who feel underserved by the US healthcare system.

This announcement comes at a time of heightened employee interest in abortion access. According to an October 2022 survey by Catalyst, a nonprofit organization focused on advancing women in the workplace, 59% of US workers want more transparency from their employers about their reproductive benefits. Julie Nugent, SVP for strategic solutions and products at Catalyst, noted that employees are "making decisions based on how their own company?or perhaps a prospective employer?and leaders are addressing both abortion access as well as reproductive care."

"We want to help employers who are looking for the best ways to care for their employees' needs, across a wide range of services, including reproductive health," said Jamie Hall, President & CEO, CirrusMD. "Leading employers recognize the need to support their employees beyond the work environment, with an expanding range of benefits and services. With CirrusMD, employees who need an abortion have direct access to safe and empathetic care."

CirrusMD has partnered with Abortion On Demand (AOD) to support pregnant people who need an abortion. AOD's platform is in full regulatory compliance, providing nationwide expertise and ensuring a board-certified physician is always available.

In addition to offering a full range of virtual care services ? from primary care to women's health ? CirrusMD continues to build trusted partnerships with other solution providers to extend the broadest array of quality healthcare services.

About CirrusMD

CirrusMD is a different kind of virtual care company. In less than 60 seconds, patients begin chatting with one of our physicians, then dictate the pace and cadence of the encounter. CirrusMD's integrated care is delivered by multi-specialty, board-certified doctors who treat a broad range of conditions ? from acute to chronic ? across a spectrum of disciplines, from primary care to specialties including behavioral health and women's health. CirrusMD is available to nearly 10 million users across all 50 states, and offered through self-funded employers, as well as commercial and government-sponsored health plans.

Learn how CirrusMD is transforming virtual care at www.cirrusmd.com.

SOURCE CirrusMD


These press releases may also interest you

at 07:10
D-Wave Quantum Inc., ("D-Wave" or the "Company") a leader in commercial quantum computing systems, software, and services, today announced financial results for its fourth fiscal quarter and year ended December 31, 2023. "Our momentum is...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Zilliant, the leader in pricing lifecycle management, today announced it recently concluded a year of rapid growth, delivering two consecutive quarters of 60%+ growth in year-over-year bookings. The company is positioned for continued record growth...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:07
MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the release of ActiveReports. NET v18. This major release includes exciting new features and improvements to the ActiveReports ecosystem....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...



News published on and distributed by: